Topical application of a novel anti‐interleukin‐17A antibody fragment penetrates psoriatic skin: Results of a randomised, double‐blind, placebo‐controlled Phase Ib study

Overview of attention for article published in Experimental Dermatology, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 2,823)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 10 news outlets

twitter: 1 X user

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 1 X post from an account with 584 followers.

See the results published today for our Phase 1b study of ZL-1102, our novel antibody fragment targeting IL-17A that we are evaluating for chronic plaque #psoriasis in today's issue of @ExpDermatol. ZL-1102 was generated by the @HUMABODY platform. https…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.